Cyclic 3',5'-adenosine Monophosphate (cAMP) Signaling in The anterior Pituitary Gland in Health and Disease
Overview
Endocrinology
Molecular Biology
Affiliations
The cyclic 3',5'-adenosine monophosphate (cAMP) was the first among the so-called "second messengers" to be described. It is conserved in most organisms and functions as a signal transducer by mediating the intracellular effects of multiple hormones and neurotransmitters. In this review, we first delineate how different members of the cAMP pathway ensure its correct compartmentalization and activity, mediate the terminal intracellular effects, and allow the crosstalk with other signaling pathways. We then focus on the pituitary gland, where cAMP exerts a crucial function by controlling the responsiveness of the cells to hypothalamic hormones, neurotransmitters and peripheral factors. We discuss the most relevant physiological functions mediated by cAMP in the different pituitary cell types, and summarize the defects affecting this pathway that have been reported in the literature. We finally discuss how a deregulated cAMP pathway is involved in the pathogenesis of pituitary disorders and how it affects the response to therapy.
Using Small Molecules to Reprogram RPE Cells in Regenerative Medicine for Degenerative Eye Disease.
Rzhanova L, Alpeeva E, Aleksandrova M Cells. 2024; 13(23).
PMID: 39682681 PMC: 11640686. DOI: 10.3390/cells13231931.
Peng J, Yuan L, Kang P, Jin S, Ma S, Zhou W J Transl Med. 2024; 22(1):892.
PMID: 39363281 PMC: 11448088. DOI: 10.1186/s12967-024-05702-w.
Urban-Sosa V, Avila-Mendoza J, Carranza M, Martinez-Moreno C, Luna M, Aramburo C Heliyon. 2024; 10(12):e33060.
PMID: 38994081 PMC: 11238054. DOI: 10.1016/j.heliyon.2024.e33060.
mutations suppress cell invasion by activating MEG3 in growth hormone-secreting pituitary adenoma.
Tang C, Zhong C, Zhu J, Yuan F, Yang J, Xu Y Oncol Res. 2024; 32(6):1079-1091.
PMID: 38827318 PMC: 11136687. DOI: 10.32604/or.2024.046007.
Hotspots of Somatic Genetic Variation in Pituitary Neuroendocrine Tumors.
Torres-Moran M, Franco-Alvarez A, Rebollar-Vega R, Hernandez-Ramirez L Cancers (Basel). 2023; 15(23).
PMID: 38067388 PMC: 10705109. DOI: 10.3390/cancers15235685.